Fjarde Ap-fonden’s 10x Genomics TXG Stock Holding History

Fjarde Ap-fonden’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,152	Closed	-$1.08M	–	559
2022 Q1	$1.08M	Sell	14,152 -8,348	-37%	-$730K	0.01%	546
2021 Q4	$3.35M	Sell	22,500 -1,000	-4%	-$153K	0.03%	486
2021 Q3	$3.42M	Hold	23,500	–	–	0.03%	492
2021 Q2	$4.6M	Hold	23,500	–	–	0.04%	437
2021 Q1	$4.25M	Sell	23,500 -1,100	-4%	-$190K	0.04%	440
2020 Q4	$3.48M	Buy	+24,600	New	+$3.57M	0.03%	470

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Fjarde Ap-fonden's TXG Position: Q2 2022 in Review

Fjarde Ap-fonden sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 14,152 shares — an estimated $1.08M sold.

Fjarde Ap-fonden first reported a position in TXG in Q4 2020 and held it in 6 quarters. The position peaked at $4.6M in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

Fjarde Ap-fonden reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
Fjarde Ap-fonden sold 14,152 10x Genomics shares in Q2 2022, an estimated $1.08M.
Fjarde Ap-fonden first reported a position in 10x Genomics in Q4 2020 and held it in 6 quarters.
Fjarde Ap-fonden's 10x Genomics position peaked at $4.6M in Q2 2021.
254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Fjarde Ap-fonden's 13F filing for Q2 2022, filed 21 Jul 2022.